$82 Million pending via Pharmaceutical Benefit Plan Settlements, separate from the Generic Pharmaceuticals Pricing Antitrust Litigation. Overview There are typically several active lawsuits and/or class action settlements that fall into the category of “pharmaceutical benefit plan settlements.” Under these cases, it is generally alleged that businesses with self-insured health plans overpaid for drugs purchased on behalf of their employees due to artificially inflated and/or

Update:  Preliminary approval has been granted (March 20, 2026) for a new Acute Care Hospital Opioids Settlement  in San Miguel Hospital Corp., et al. v. Richard Sackler, et al.  (D.N.M.), establishing a settlement fund of approximately $174.2 million . This settlement represents an additional recovery opportunity specifically for Acute Care Hospitals, stemming from allegations that members of the Sackler family and related entities contributed to the opioid epidemic and the

For most merchants, payment processing is just part of doing business—until the costs start adding up. What many don’t realize is that they may be entitled to recover a portion of the fees they’ve already paid. Every transaction carries layers of expense—interchange fees, network fees, processor markups, and compliance costs—that quietly erode margins over time. These costs are often accepted as fixed. They’re not. Many of these practices have been challenged in court, creati

The $2.67 billion Blue Cross Blue Shield Provider Settlement  addressed market power. The $575 million Sutter Health Settlement  challenged restrictive contracting practices. The ongoing Acute Care Hospital Opioid Settlements  focused on accountability and cost recovery. Each of those cases examined large-scale structural conduct in healthcare. The next wave of healthcare litigation is shifting direction. It is less about traditional market share disputes and more about syste